Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow IRADIMED CORP

Get SEC filing alerts via email and in your feed for IRADIMED CORP

IRMD

IRADIMED CORP

About IRADIMED CORP

Iradimed Corporation develops MRI-compatible medical devices, including infusion pumps and vital signs monitors, designed for safe operation within strong magnetic fields. Its products serve hospitals and critical care facilities worldwide, enabling safe, accurate patient monitoring and fluid delivery during MRI procedures. The company’s innovative, non-magnetic technology offers a competitive advantage in the expanding MRI safety market, focusing on patient safety, workflow efficiency, and regulatory compliance.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from IRADIMED CORP

1
1
IRADIMED CORP IRADIMED Reports 13% Revenue Growth to $21.98 Million in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
IRADIMED CORP IRadimed Corporation Reports 14.4% Revenue Growth to $83.8 Million for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
IRADIMED CORP IRADIMED Reports 16% Revenue Growth to $21.2 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
IRADIMED CORP IRADIMED Reports 14% Revenue Growth to $20.4 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
IRADIMED CORP IRADIMED Reports 11% Revenue Growth to $19.5 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
IRADIMED CORP IRadimed Corporation Reports 12% Revenue Growth to $73.2 Million for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
IRADIMED CORP Iradimed Corp Reports Strong Q3 and Nine-Month Financial Results with Revenue and Net Income Growth

Via official filing (AI summary) | over 1 year ago | 0 comments